Risk of Acute Kidney Injury after Exposure to Gadolinium-Based Contrast in Patients with Renal Impairment

REFERENCES

• Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354:379–386.
   PubMed Web of Science ®Google Scholar
• Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930–936.
   PubMed Web of Science ®Google Scholar
• Kaufman JA, Geller SC, Waltman AC. Renal insufficiency: Gadopentetate dimeglumine as a radiographic contrast agent during peripheral vascular interventional procedures. Radiology. 1996;198:579–581.
   PubMed Web of Science ®Google Scholar
• Boyden TF, Gurm HS. Does gadolinium-based angiography protect against contrast-induced nephropathy?: A systematic review of the literature. Catheter Cardiovasc Interv. 2008;71:687–693.
   PubMedGoogle Scholar
• Robert A, Bonneville F, Miralbes S, . Gadolinium in arteriography and interventional radiology: 39 patients. J Radiol. 2002;83:1759–1763.
   PubMedGoogle Scholar
• Sam II AD, Morasch MD, Collins J, Song G, Chen R, Pereles FS. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg. 2003;38:313–318.
   PubMed Web of Science ®Google Scholar
• Thomsen HS. Gadolinium-based contrast media may be nephrotoxic even at approved doses. Eur Radiol. 2004;14:1654–1656.
   PubMed Web of Science ®Google Scholar
• Ergün I, Keven K, Uruç I, . The safety of gadolinium in patients with stage 3 and 4 renal failure. Nephrol Dial Transplant. 2006;21:697–700.
   PubMed Web of Science ®Google Scholar
• Akgun H, Gonlusen G, Cartwright JR, Suki WN, Truong LD. Are gadolinium-based contrast media nephrotoxic? A renal biopsy study. Arch Pathol Lab Med. 2006;130:1354–1357.
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470.
   PubMed Web of Science ®Google Scholar
• Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351:159–169.
   PubMed Web of Science ®Google Scholar
• Ailawadi G, Stanley JC, Williams DM, Dimick JB, Henke PK, Upchurch Jr. GR. Gadolinium as a nonnephrotoxic contrast agent for catheter-based arteriographic evaluation of renal arteries in patients with azotemia. J Vasc Surg. 2003;37:346–352.
   PubMed Web of Science ®Google Scholar
• Spinosa DJ, Matsumoto AH, Angle JF, Hagspiel KD, McGraw JK, Ayers C. Renal insufficiency: Usefulness of gadodiamide-enhanced renal angiography to supplement CO2-enhanced renal angiography for diagnosis and percutaneous treatment. Radiology. 1999;210:663–672.
   PubMed Web of Science ®Google Scholar
• Tombach B, Bremer C, Reimer P, . Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: Results of a randomized study. Radiology. 2001;218:651–657.
   PubMed Web of Science ®Google Scholar
• Star RA. Treatment of acute renal failure. Kidney Int. 1998;54:1817–1831.
   PubMed Web of Science ®Google Scholar
• Elmståhl B, Nyman U, Leander P, . Iodixanol 320 results in better renal tolerance and radiodensity than do gadolinium-based contrast media: Arteriography in ischemic porcine kidneys. Radiology. 2008;247:88–97.
   PubMedGoogle Scholar
• Heinrich MC, Kuhlmann MK, Kohlbacher S, . Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: In vitro study. Radiology. 2007;242:425–434.
   PubMed Web of Science ®Google Scholar
• Tervahartiala P, Kivisaari L, Kivisaari R, Virtanen I, Standertskjöld-Nordenstam CG. Contrast media-induced renal tubular vacuolization. A light and electron microscopic study on rat kidneys. Invest Radiol. 1991;26:882–887.
   PubMed Web of Science ®Google Scholar
• Nyman U, Elmståhl B, Leander P, Nilsson M, Golman K, Almén T. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology. 2002;223:311–318.
   PubMed Web of Science ®Google Scholar
• Heyman SN, Reichman J, Brezis M. Pathophysiology of radiocontrast nephropathy: A role for medullary hypoxia. Invest Radiol. 1999;34:685–691.
   PubMed Web of Science ®Google Scholar
• Persson PB, Patzak A. Renal hemodynamic alterations in contrast medium-induced nephropathy and the benefit of hydration. Nephrol Dial Transplant. 2005;20(Suppl. 1):i2–i5.
   PubMedGoogle Scholar
• Tumlin J, Stacul F, Adam A, . Pathophysiology of contrast-induced nephropathy. Am J Cardiol. 2006;98:14K–20K.
   PubMed Web of Science ®Google Scholar
• Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol. 2000;11:177–182.
   PubMed Web of Science ®Google Scholar
• Cowper SE. Nephrogenic fibrosing dermopathy: The first 6 years. Curr Opin Rheumatol. 2003;15:785–790.
   PubMed Web of Science ®Google Scholar
• Grobner T. Gadolinium—A specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006;21:1104–1108.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. FDA news: FDA requests boxed warning for contrast agents used to improve MRI images. Food and Drug Administration Web site 2007. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108919.htm . Accessed November 25, 2010.
   Google Scholar
• Froissart M, Rossert J, Jaquot C, Paillard M, Houillier P. Predictive performance of the modification of diet in renal disease and Cockcroft–Gault equations for estimating renal function. J Am Soc Nephrol. 2005;16:763–773.
   PubMed Web of Science ®Google Scholar
• Ma C-Y, Zuo L, Chen J-H, . Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–2944.
   PubMed Web of Science ®Google Scholar